Integrating Genetic Info With Breast Cancer Risks May Refine Prognosis
Incorporating genetic information—known as gene expression signatures—with clinical and other risk factors for breast cancer may help refine estimates of relapse-free survival and predicted response to chemotherapy, according to a study in the April 2 issue of JAMA.
Read More